- Previous Close
0.0080 - Open
0.0080 - Bid 0.0070 x --
- Ask 0.0080 x --
- Day's Range
0.0080 - 0.0080 - 52 Week Range
0.0060 - 0.0160 - Volume
93,853 - Avg. Volume
0 - Market Cap (intraday)
3.691M - Beta (5Y Monthly) -0.21
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date Feb 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Anagenics Limited engages in the health wellness and beauty business. The company develops, manufactures, and markets anti-ageing hair care products under the évolis brand; and skin, hair, and body care products under the Uspa brand name. It also imports and distributes skin care and wellbeing products to spas, clinics, salons, retail stores, and online in Australia, New Zealand, and the Pacific Islands. The company was formerly known as Cellmid Limited and changed its name to Anagenics Limited in December 2021. Anagenics Limited was incorporated in 2004 and is based in Sydney, Australia.
anagenics.com--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: AN1.AX
View MorePerformance Overview: AN1.AX
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AN1.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AN1.AX
View MoreValuation Measures
Market Cap
3.69M
Enterprise Value
2.84M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.30
Price/Book (mrq)
1.36
Enterprise Value/Revenue
0.26
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-82.78%
Return on Assets (ttm)
-27.30%
Return on Equity (ttm)
-135.49%
Revenue (ttm)
7.26M
Net Income Avi to Common (ttm)
-6.38M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
471.13k
Total Debt/Equity (mrq)
27.93%
Levered Free Cash Flow (ttm)
-1.26M